Skip to main content

OrbiMed — Portfolio, Page 6

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

289
Companies
$23.6B
Total invested
$104.0M
Avg. check
33
Industries
Health Care 18Biotechnology 14Medical 9Therapeutics 9Biopharma 6Pharmaceutical 6+27 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 121144 of 289
Augmedix
November 2023

Medical documentation, Point-of-care notifications, Structured data, Open ecosystem

Electronic Health Record (EHR) · San Francisco$25.0M Post-IPO Equity
Verastem Oncology
November 2025

Verastem is a biopharmaceutical company developing new medicines to improve the lives of patients with RAS/MAPK pathway-driven cancers.

Biopharma · Needham$90.0M Post-IPO Equity
TELA Bio
November 2025

TELA Bio is a life science company that specializes in soft tissue reconstruction.

Biotechnology · Malvern$60.0M Post-IPO Debt
TigerConnect
January 2022

TigerConnect is a healthcare collaboration platform that streamlines clinical workflows and systems.

Collaboration · Santa Monica$300.0M Private Equity
Iambic
November 2025

Iambic is disrupting the therapeutics landscape with its unique AI-driven drug-discovery platform.

Artificial Intelligence (AI) · San Diego$100.0M Venture - Series Unknown
Adicet Bio
October 2025

Adicet Bio is a biotechnology company discovering and developing first-in-class allogeneic gamma delta CAR t cell therapies for cancer

Biopharma · Redwood City$80.0M Post-IPO Equity
Forward Therapeutics
October 2023

Forward Therapeutics is a biopharma comapny targeting treatment of chronic inflammatory disorders.

Health Care · Palm Beach Gardens$50.0M Series A
Harmony Biosciences
October 2024

Harmony Biosciences is a pharmaceutical company that develops and commercializes novel therapies for rare neurological disorders.

Biopharma · Plymouth Meeting$248.0M Post-IPO Secondary
Repare Therapeutics
October 2021

Repare Therapeutics is a developer of oncology drugs designed to target specific vulnerabilities of tumor cells.

Biotechnology · Saint Laurent$101.2M Post-IPO Equity
X4 Pharmaceuticals
October 2025

X4 Pharmaceuticals is a clinical-stage oncology company developing oral small molecule CXCR4 antagonists for the treatment.

Biotechnology · Cambridge$155.3M Post-IPO Equity
Harpoon Therapeutics
October 2023

Harpoon Therapeutics is a clinical-stage immunotherapy company focused on the development of novel T-cell recruiting biologic therapies.

Biotechnology · South San Francisco$100.0M Post-IPO Equity
Tricida
October 2022

Tricida operates in the healthcare industry focusing on pharmaceutical business.

Health Care · Menlo Park$125.0M Post-IPO Debt
PIC Therapeutics
October 2022

PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.

Biotechnology · Natick$35.0M Series A
Scout Bio
October 2021

Scout Bi is a biotechnology company that specializes in veterinary, animal health, and gene therapy.

Biotechnology · Philadelphia$33.0M Series B
VectivBio
October 2022

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

Biotechnology · Basel$125.0M Post-IPO Equity
Stairway Medical
March 2026

Stairway Medical is a developer of implantable brain-computer interface technology.

Health Care · Pudong$72.6M Series Unknown
QL Biopharma
March 2026

QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.

Biopharma · Changping$72.8M Series C
Corvus Pharmaceuticals
January 2026

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company.

Biopharma · Burlingame$201.0M Post Ipo Equity
Mendra
January 2026

Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.

Artificial Intelligence (AI) · San Francisco$82.0M Series A
Pee Safe
January 2026

Started in 2013, Redcliffe Hygiene Private Limited is India's fastest growing hygiene company.

Consumer Goods · Gurgaon$32.0M Series C
AirNexis Therapeutics
January 2026

AirNexis Therapeutics develops clinical-stage therapies for chronic obstructive pulmonary disease and other pulmonary conditions.

Biotechnology · Palo Alto$200.0M Series A
Biobeat
December 2025

Biobeat is a med-tech company that develops remote patient monitoring and data collection tool.

Biotechnology · Boca Raton$50.0M Series B
BIOMx
December 2025

BIOMx is a microbiome therapeutics company developing synbio phage therapies to eradicate harmful bacteria in chronic diseases.

Biotechnology · Ness Ziona$3.0M Post Ipo Equity
Yarrow
December 2025

Yarrow is developing a first-in-class antibody targeting TSHR for the treatment of Graves’ disease and thyroid eye disease.

Business Intelligence · New York$200.0M Series Unknown

Where OrbiMed invests

Health Care18
Biotechnology14
Medical9
Therapeutics9
Biopharma6
Pharmaceutical6

About OrbiMed's portfolio

How many companies has OrbiMed invested in?

OrbiMed has invested in 289 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does OrbiMed invest in?

OrbiMed's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Biopharma. The firm invests across 33 different industry categories.

What is OrbiMed's largest investment?

Among tracked funding rounds, TigerConnect received $300.0M in a Private Equity round. OrbiMed's total known invested capital is $23.6B.

What is the average investment size for OrbiMed?

OrbiMed's average investment size is $104.0M across its portfolio of 289 companies.

What are OrbiMed's most recent investments?

Recent OrbiMed portfolio additions include Augmedix, Verastem Oncology, TELA Bio, TigerConnect, Iambic. These companies were founded in 2020 or later.

Reach the founders behind these 289 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →